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Abstract
Background: Circulating Endothelial Precursors (PB-EPCs) are involved in the maintenance of the
endothelial compartment being promptly mobilized after injuries of the vascular endothelium, but
the effects of a brief normobaric hypoxia on PB-EPCs in healthy subjects are scarcely studied.
Methods: Clinical and molecular parameters were investigated in healthy subjects (n = 8) in basal
conditions (T0) and after 1 h of normobaric hypoxia (T1), with Inspiratory Fraction of Oxygen set
at 11.2% simulating 4850 mt of altitude. Blood samples were obtained at T0 and T1, as well as 7
days after hypoxia (T2).
Results: In all studied subjects we observed a prompt and significant increase in PB-EPCs, with a
return to basal value at T2. The induction of hypoxia was confirmed by Alveolar Oxygen Partial
Pressure (PAO2) and Spot Oxygen Saturation decreases. Heart rate increased, but arterial
pressure and respiratory response were unaffected. The change in PB-EPCs percent from T0 to T1
was inversely related to PAO2 at T1. Rapid (T1) increases in serum levels of hepatocyte growth
factor and erythropoietin, as well as in cellular PB-EPCs-expression of Hypoxia Inducible Factor-
1α were observed.
Conclusion: In conclusion, the endothelial compartment seems quite responsive to standardized
brief hypoxia, possibly important for PB-EPCs activation and recruitment.
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Background
The identification in the peripheral blood (PB) of
endothelial precursors (EPCs) derived from bone marrow
(BM) and the demonstration of their prompt mobiliza-
tion, incorporation, and differentiation to the sites of
injury have suggested that EPCs could serve as endothelial
reparative reserve of the damaged vascular endothelium
[1-3]. In addition, in an experimental model of tissue
injury it has been demonstrated that, even when injected
peripherically, cells derived from BM are able to home to
the site of damage [4] contributing to neovessel formation
[5]. Therefore, the frequency of PB-ECs has been proposed
as diagnostic, therapeutic or prognostic marker of vascular
injury and neovascularization [6-9]. Unfortunately, the
majority of clinical studies on EPCs focuses on the role of
these cells in cardiovascular diseases and no systematic
studies exist regarding their variations in healthy subjects,
for example under hypoxic conditions. Pathologic tissue
ischemia in experimental animal models has been dem-
onstrated to increase the frequency of EPCs, thereby con-
tributing to neovascularization. Cytokines seem to be
involved in the mobilization of BM-EPCs [10]. Systemic
administration of hepatocyte growth factor (HGF), a mul-
tifunctional cytokine involved in tissue repair, induces
myocardial angiogenesis which contributes to the
improvement in cardiac performance of mice after myo-
cardial infarction [11]. It is known that HGF may exert
direct or indirect effects on endothelial cells, also through
Vascular Endothelial Growth Factor (VEGF) production
[12,13]. The expression of Met, the specific receptor for
HGF, is increased in the myocardial infarcted area, where
it coexists with CD31, CD34 and WWF-positive cells [11].
The possible role of HGF in activation and recruitment of
EPCs in ischemic areas is still unknown. The chemokine
SDF-1/CXCL12 and its receptor CXCR4 are critical media-
tors of the ischemic specific recruitment of circulating
EPCs, a loop probably regulated by hypoxia via Hypoxia
Inducible Factor-1 (HIF-1) transcription factor activation
[14]. HIF-1 is the heterodimeric (α/β) transcription factor
that controls tissue oxygen homeostasis [15-17]. The
involvement of HGF in the expression of the ligand/recep-
tor couple CXCL12/CXCR4 has not been studied in EPCs,
but we have demonstrated that HGF induces CXCR4 in
carcinomas [18,19].
Under physiological conditions, exercise is known to
upregulate EPCs and to decrease the rate of EPCs apopto-
sis [20]. Furthermore, in vitro induced-anoxia has been
shown to enhance the differentiation of peripheral blood
mononuclear cells from healthy subjects into EPCs [21].
In a recent paper we have shown that high-altitude
hypoxia and exercise oxygen demands are strong stimuli
for clonogenic endothelial cell activation [22]. At this
regard, no studies are currently available in healthy sub-
jects linking the PB-EPCs response with the hypoxia-spe-
cific regulation system. However, hypoxia during ascent to
high altitude is responsible for an enhanced expression of
Erythropoietin (Epo) and an augment of vascular tone
closely related to the increased serum concentration of
endothelin (ET)-1. Epo and ET-1 are known target genes
of HIF-1 [23].
The present paper aims to assess the effect of a brief stand-
ardized normobaric hypoxia in healthy subjects on the
frequency of PB-EPCs, and to evaluate early molecular
events implicated in the activation and/or recruitment of
these cells. To this purpose, we studied the involvement of
HIF-1 transcription factor by measuring the expression of
the inducible α-subunit and of HIF-1 target- genes. Based
on the knowledge in pathological conditions, we chose
genes involved in angiogenesis, such as HGF and ET-1, as




We enrolled 8 caucasic male healthy non-smokers, non-
obese, normo-cholesterol, normotensive, not currently
under pharmacological treatment volunteers between our
attendant students. No subject had a history of pulmo-
nary disease or respiratory symptoms and all were native
sea level dwellers, who had not been at altitude in the pre-
ceding three months. Most were not regular exercisers
who took part in a range of activities, mainly football. As
normal reference, PB-EPCs values obtained in a previous
study were used [24]. The study was approved by the Eth-
ical Committee and the subjects signed a consent form.
Simulated altitude (normobaric hypoxia)
Subjects set quietly breathing room air for five minutes
before breathing an oxygen mixture at 11.2% (corre-
sponding to 4850 m) for 1 h by using an hypoxicator
(GO2 Altitude, Biomedtech, Australia).
Cardiorespiratory parameters
During the experiment the main cardiorespiratory param-
eters were measured. Recordings of Systolic and Diastolic
Pressures (SBP, DBP) and heart rate (HR) were obtained
non-invasively (Finapress, Ohmeda, Louisville-CO, USA);
a gas analyzer (Cosmed Quark b2, Italy) and an oxygen
saturimeter (Envitec, Wismar, G) were used to obtain the
following parameters: Inspiratory Fraction of Oxygen
(FiO2), Alveolar Oxygen Partial Pressure (PAO2), Spot
Oxygen Saturation (SpO2), Respiratory Frequency (RF),
Tidal Volume (Vt). All cardiorespiratory parameters were
measured continuously except SBP and DBP, that were
measured at 10 min time intervals.Respiratory Research 2007, 8:58 http://respiratory-research.com/content/8/1/58
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Blood sampling and analysis of Endothelial Precursors
A 10 ml PB-sample was obtained from all subjects at each
time studied: before (T0) and at the end of the experimen-
tal hypoxia (T1), and after 7 days (T2). The frequency of
PB-EPCs, defined as KDR+/CD34+/CD45-, was obtained
by Flow Cytometry (FACScan, Becton Dickinson, San
Jose, CA) according to a previously described procedure
on 100,000 events per sample [24].
Measurement of HGF, Epo and ET-1 levels in the serum
HGF was measured in human serum with Quantikine
Immunoassay Kit (R&D System, Minneapolis, MN) fol-
lowing the manufacturer's instructions. Serum concentra-
tions of soluble Epo and ET-1 were assessed by
commercial enzyme-linked immunosorbent assays (R&D
System). The normal reference values for Epo were within
3.3–16.6 mIU/ml. For ET-1 the sensitivity was 0.14 pg/ml.
All the values were calculated using standard curves gener-
ated with specific standards, according to the manufac-
turer's recommendations [25].
Immunofluorescence assay
Slides were prepared with EPC cells, obtained with immu-
nobeads CD34+ separation, using a cyto-spin. For fluores-
cence microscopy, the cells were permeabilised with 0.2 %
Triton × 100 and were incubated at room temperature
with anti HIF-1α antibody (1:50, Transduction Laborato-
ries, Lexington, KY) for 2 h. Non permeabilised-cells were
incubated at room temperature with anti CXCR4 antibody
(10 μg/ml, MAB172 R&D System) for 1.5 h. Green fluo-
rescent Alexa Fluor-488 (1:800), used as secondary anti-
body, was let to react for 1 h in the dark. Nuclear staining
was performed with DAPI (1:2000). The coverslips were
mounted with Entellan (Merck, Darmstadt, Germany),
and the cells were examined with a fluorescence micro-
scope (Nikon Eclipse 80i with digital camera DS5MC) at
room temperature in the dark. Images were collected
through the specimens at 400 × magnification, using an
objective Plan APO VC (N.A. 1.40). Analysis of the images
was performed according to a previously described proce-
dure [19].
Statistical analysis
Data obtained for cardiorespiratory parameters were ana-
lyzed using a computer statistical software (SPSS – Rel
6.1.1; SPSS Inc., Chicago, Ill). All the quantitative varia-
bles were tested for Gaussian distribution with the Kol-
mogorov-Smirnov test. Changes in any of the studied
variables at each time intervals were tested by ANOVA.
The relationship between PB-EPCs changes from T0 to T1
and other variables at T1 was tested by regression analysis.
In all cases, p < 0.05 was considered significant.
Results
Evaluation of clinical parameters in healthy subjects 
exposed to normobaric hypoxia
All subjects completed the test as outlined in the methods
section. The induced hypoxia, consisting in an effective
FiO2 reduction from 20.9 ± 0.5 % to 11.8 ± 0.9 % (Δ- 43.2
± 5.3%), was confirmed by a significant decrease in PAO2
and SpO2, respectively, from 104.5 to 30.2 mmHg (p <
0.0001) and from 97.5 % to 86.8 % (p = 0.0005). In all
subjects the experimental hypoxia was associated with a
prompt and significant increase in the frequency of PB-
EPCs, that raised from 0.38 ± 0.56 to 0.65 ± 0.72 cells/ml
(p= 0.016) with a return to basal value 7 days after the
hypoxia (Table 1). The change in the frequency of PB-
EPCs elements was well documented by cytofluorimetric
analysis by evaluating CD34+ cells at T0 (Figure 1C) and
after hypoxia exposure (T1) (Figure 1D), and excluding
CD45+cells (Figure 1B). The significant change in PB-
EPCs from T0 to T1 was inversely related to the levels of
PAO2 at T1 (r = 0.73; p = 0.03), suggesting that PAO2 was
the trigger of the hypoxia-specific regulation system acting
on the endothelial compartment (Figure 2). Furthermore,
the gain of the PB-EPCs response was high since a reduc-
Table 1: Effects of hypoxia on cardiorespiratory parameters and PB-EPCs
T0 T1 T2 ΔT0-T1% T0 vs T1 p T1 vs T2 p
FiO2, % 20.9 ± 0.5 11.8 ± 0.9 21.2 ± 0.5 - 43.2 ± 5.3 < 0.0001 < 0.0001
PAO2, mmHg 104.5 ± 14.9 30.2 ± 14.0 99.8 ± 15.8 - 71.8 ± 13.4 < 0.0001 < 0.0001
SpO2, % 97.5 ± 1.4 86.8 ± 4.7 96.9 ± 05 - 10.9 ± 5.0 0.0005 0.0005
RF, breaths/min 16.0 ± 2.9 14.4 ± 3.4 15.8 ± 3.0 - 8.3 ± 21.6 0.235 0.118
Vt, L 0.57 ± 0.09 0.56 ± 0.26 0.6 ± 0.2 - 2.2 ± 43.6 0.937 0.426
HR, beats/min 64.0 ± 8.8 77.4 ± 10.8 66.6 ± 10.3 + 20.9 ± 4.3 < 0.0001 0.002
SBP, mmHg 124.7 ± 4.9 120.3 ± 8.6 122.0 ± 9.0 - 3.5 ± 4.7 0.072 0.645
DBP, mmHg 71.1 ± 3.1 73.0 ± 5.6 76.3 ± 8.2 + 2.7 ± 8.6 0.418 0.116
PB-EPCs, cells/μL 0.38 ± 0.56 0.65 ± 0.72 0.14 ± 0.20 + 237.1 ± 264.5 0.016 0.0491
PB-EPCs, peripheral blood endothelial precursors cells; T0. baseline; T1, after 1h of standardized hypoxia; T2, 7 days after hypoxia; FiO2, Inspiratory 
Fraction of Oxygen ; PAO2, Alveolar Oxygen Partial Pressure; SpO2, Spot Oxygen Saturation; RF, Respiratory Frequency; Vt, Tidal Volume; HR; 
Heart Rate; SBP, Systolic Blood Pressure; DBP, Diastolic Blood Pressure.
Values are expressed as means ± SD. A p value < 0.05 was considered significant.Respiratory Research 2007, 8:58 http://respiratory-research.com/content/8/1/58
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tion of PAO2 from 50 mmHg, where the frequency of PB-
EPCs is almost unchanged, to 40 mmHg increased the fre-
quency of PB-EPCs of about 100%.
In all subjects the cardiac response was characterized by a
significant increase in HR (from 64.0 to 77.4 b/min; p <
0.0001) as well as by little reductions in SBP (5/8 sub-
jects) and increases in DBP (5/8 subjects), that did not
reach the statistical significance. The pulmonary response
was limited, showing little decreases in RF (6/8 subjects)
and in Vt (4/8 subjects) not statistically significant (Table
1).
Oxygen responsive molecules after normobaric hypoxia
Baseline levels of HGF (2.9 ± 0.3 ng/ml) were in the nor-
mal range reported by the manufacturer; at T1 5/8 subjects
showed increases in HGF levels (2.5–2.8-fold relative to
T0) (Figure 3A).
The expression of HIF-1α and CXCR4 was assessed by
immunofluorescence using PB-EPC, and representative
results are shown (Figure 3B). At T1 the expression of HIF-
1α protein was strongly enhanced, as shown by the
increased fluorescent signal throughout the cell including
the nucleus (see merge, c). Stainings with the secondary
Flow cytometry evaluation of circulating endothelial precursors cells (EPCs) Figure 1
Flow cytometry evaluation of circulating endothelial precursors cells (EPCs). (A) Representative panel showing the analysis gate 
used to exclude platelets and debris. (B) The gate used to exclude CD45-positive hematopoietic cells. (C, D) Representative 
panels showing the EPCs before (T0) and after (T1) hypoxia exposure. PerCP, peridin chlorophyll protein; PE, phycoerythrin; 
FITC, fluorescein isothiocyanate.Respiratory Research 2007, 8:58 http://respiratory-research.com/content/8/1/58
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antibody alone were performed (negative controls), and
we did not observe differences in the fluorescence
between T0 and T1 (data not shown). Due to the scarce
number of PB-EPC collected, it was impossible to perform
a quantitative analysis of HIF-1α protein-levels by West-
ern blot. We did not observe changes of CXCR4 protein
expression at this early time after hypoxia exposure. After
hypoxia a prompt and significant increase in the serum
Epo levels was observed in 7/8 subjects included in the
experiment, with a change from 7.07 ± 1.04 to 9.91 ± 2.26
mIU/ml (p = 0.009). This increase was directly correlated
with the change in PB-EPCs from T0 to T1 (r = 0.65; p <
0.05). A concurrent increase in ET-1 serum levels was
observed, that did not reach the statistical significance
(from 0.18 ± 0.20 to 0.49 ± 0.58 pg/ml, p = 0.197) (Figure
3C, D).
Discussion
It is well established that endothelial cells acquire several
functional properties in response to diverse extracellular
stimuli, and this expression of an altered phenotype is
referred to as endothelial cell activation [26]. While it is
recognized that endothelial cell activation has a principal
role in host defence, recent studies also demonstrate that
endothelial cells are capable of complex molecular
responses against various forms of stress including
hypoxia. Hypoxic stimulus on endothelial cells causes
transcriptional induction of genes encoding growth fac-
tors for blood vessels and remodelling enzymes [27].
These events are associated with endothelial cell clono-
genic activation resulting in loosing/acquiring specific
surface markers.
In the present study we have shown that the endothelial
compartment promptly reacted to acute hypoxia by
increasing the CD34/KDR responsive elements, that are
considered PB-EPC. Since KDR is the Fetal liver kinase-1
(Flk-1), i.e. the VEGF receptor, this switch might be func-
tional to the establishment of VEGF-responsive cells [28].
The activation of the PB-EPCs observed was probably
related to the systemic release of Epo, and a direct correla-
tion was found between the change in PB-EPCs from T0 to
T1 and the serum levels of Epo. The PB-EPCs activation
might be mediated by HIF-1α, that is known to regulate
the expression of a wide variety of genes involved in
neoangiogenesis under various pathophysiological condi-
tions [15,23].
At T1 in PB-EPCs, we observed an enhanced expression of
HIF-1α protein, the hypoxia inducible-subunit of the het-
erodimeric transcription factor HIF-1. Thus, the endothe-
lial compartment seemed to promptly react to a short
hypoxia exposure in healthy subjects. Under normoxic
conditions, HIF-1α is hydroxylated by prolyl hydroxy-
lases. This reaction enables the von Hippel-Lindau (VHL)
protein-binding and HIF-1α degradation by the proteas-
ome. Under hypoxic conditions, prolyl hydroxylases are
inactive, HIF-1α is stabilized and translocates to the
nucleus as an heterodimer with the constitutive HIF-1β.
This control mechanism, i.e. protein stabilization, might
be responsible for the rapid enhancement in HIF-1α
expression observed after normobaric hypoxia.
The HIF-1 complex binds to hypoxia-responsive elements
(HRE) sequences in the promoters of target genes, causing
activation of transcription. Under hypoxic conditions,
HIF-1 is known to transactivate VEGF, Epo, and ET-1 as
well as genes involved in cell recruitment such as the
chemokine receptor CXCR4 and the ligand SDF-1/
CXCL12 [14,23,29,30]. In our study despite an absolute
increase in serum ET-1, the changes observed were not sig-
nificant. Also, CXCR4 expression at T1 in PB-EPCs was
unaffected. The lack of significant changes in ET-1 and
CXCR4 was probably related to the short exposure to
hypoxia. In fact, molecular events controlled at transcrip-
tional/translational level need longer times to occur. Con-
sistently HGF, a growth factor involved in
neoangionenesis like VEGF [12,13], was found increased
in the serum of healthy subjects exposed to normobaric
hypoxia. HGF is known to be rapidly released in the blood
after various types of tissue injuries. Present as a pro-form
in tissue extarcellular matrix, HGF is activated and
released by proteolytic mechanisms [31]. Thus, HGF
seemed to play a critical role in early stages of EPCs acti-
Regression plot showing the correlation between changes in  PB-EPCs from T0 to T1 and levels of PAO2 at T1 (r = 0.73; p  = 0.03) Figure 2
Regression plot showing the correlation between changes in 
PB-EPCs from T0 to T1 and levels of PAO2 at T1 (r = 0.73; p 
= 0.03). PB-EPCs ΔT0-T1, peripheral blood endothelial pre-
cursors change from T0 to T1; PAO2 T1, Alveolar Oxygen 
Partial Pressure at T1.Respiratory Research 2007, 8:58 http://respiratory-research.com/content/8/1/58
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vation, and might contribute to the triggering of later
molecular events.
Studies are in progress at examining these possible
changes dependent on early HIF-1 alpha expression,
Molecular changes in serum and PB-EPCs after normobaric hypoxia Figure 3
Molecular changes in serum and PB-EPCs after normobaric hypoxia. Normal subjects were examined before (T0) and 1 h (T1) 
after experimental hypoxia. Serum samples were used for HGF (A), Epo (C) and Et-1 (D) evaluation. HGF data are reported as 
relative fold-increases, calculated using the absolute values (T0 = 2.9 ± 0.3 ng/ml). All the data were analysed by ANOVA, and 
the values reported are the means ± S.E. of experiments performed in triplicate. A p value < 0.05 was considered significant. 
(B) PB-EPCs, prepared on slides, were used to examine HIF-1α and CXCR4 expression by immunofluorescence. Specific stains 
with anti-HIF-1α or anti-CXCR4 antibody followed by the appropriate secondary antibody (green, a); nuclear staining with 
DAPI (blu, b); merged image (c). Images were taken using fluorescence microscopy at 400 × magnification.Respiratory Research 2007, 8:58 http://respiratory-research.com/content/8/1/58
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regarding for example the transcription via HIF-1 of
CXCR4 and Met receptors important for cell scattering
and homing [11,14]. Met expression possibly enhances
the sensitivity to HGF. Also HIF-1 expression, regarding
for example CXCR4 and Met receptors important for cell
scattering and homing [11,14]. Met expression possibly
enhances the sensitivity to HGF. Also HIF-1 might regu-
late its transcription due to the presence of HREs in the
promoter, amplifying therefore the response to hypoxia
[32].
The hypoxic cardiorespiratory response is a complex inter-
play between several distinct mechanisms, and the O2
level-decrease is sensed by specialized chemoreceptor
cells that regulate cardiovascular and ventilatory response
[33]. The normal hemodynamic response to acute
hypoxia consists of an increase in HR and a modulation
of the vascular tone, with vasodilatation of peripheral ves-
sels and constriction of the vessels of the pulmonary vas-
culature to shunt blood away from the poorly ventilated
region. In our subjects the increase in HR is prompt and
prevalent (8/8 subjects), confirming that small reductions
in PAO2 are detected by peripheral chemoreceptors elicit-
ing the sympathetic chemoreflex [33]. On the ventilatory
side, the normal response consists of a gradual increase in
ventilation that intensifies over the following hours and
days [34]. This ventilatory response was not univocally
observed in our subjects probably because the hypoxic
exposure was too short to recruit the carotid chemorecep-
tors [35].
The wide range of oxygen tensions found in healthy tissue
makes it difficult to establish an universal value to define
hypoxia [36]. Based on the medical definition of high alti-
tude, consisting in an elevation of 2700–5500 m above
sea level [33], in our study we have set the FiO2 to an alti-
tude of 4850 mt. On the endothelial point of view, the
definition of hypoxia could be the level of oxygen at
which the clonogenic PB-EPCs response starts. Further-
more, this cellular response might be used for studies
aimed to predict the adverse effects of high altitude since
it has been shown that limited informations can be
obtained by assessing only cardiorespiratory physiologi-
cal variables at sea level and at a range of simulated alti-
tudes [37].
Study limitations
On the technical point of view, the main limitations of all
studies based on circulating EPCs enumeration consist in
the lack of a uniform immunophenotype definition of
EPCs and therefore of an experimental method to discrim-
inate between different populations [24]. Furthermore we
do not provide any informations on EPCs function such
as migration or ability to form colonies; however at this
regard we have previously shown that high-altitude
hypoxia and exercise is able to switch on the endothelial
colony-forming unit capacity [22].
Conclusion
In conclusion, the cellular and molecular data indicate an
evident excess in the response of the endothelial compart-
ment when considering a physiological stimulation. In
healthy subjects the frequency of PB-EPCs may be consid-
ered as a marker of endothelial activation after exposure
to physiological normobaric hypoxia, corresponding to
an altitude of 4850 mt, that may be important for neovas-
cularization. This study may contribute to a better under-
standing of the molecular mechanisms involved in the
early steps of the normobaric hypoxia. Even if hypoxia is
a potent modulator of gene expression influencing the
expression of approximately 1.0% of the genes in the
genome [35], the identification of a specific oxygen sensor
remains elusive. Studies are in progress to evaluate late
events responsible for PB-EPCs homing to hypoxic tissues.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
MMC designed research, collected and analyzed data,
wrote and critically revised the paper; MAD participated to
the design of the research, analyzed data, and critically
revised the paper; AP, MC, IS, EM, ER, MZ, and FG per-
formed research; RP analyzed data, wrote and critically
revised the paper; AC critically revised the paper; FM criti-
cally revised the paper.
References
1. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M,
Kearne M, Magner M, Isner JM: Bone marrow origin of endothe-
lial progenitor cells responsible for postnatal vasculogenesis
in physiological and pathological neovascularization.  Circ Res
1999, 85:221-228.
2. Iwami Y, Masuda H, Asahara T: Endothelial progenitor cells:
past, state of the art, and future.  J Cell Mol Med 2004, 8:488-497.
3. Hristov M, Erl W, Weber PC: Endothelial progenitor cells:
mobilization, differentiation, and homing.  Arterioscler Thromb
Vasc Biol 2003, 23:1185-1189.
4. Ciulla MM, Lazzari L, Pacchiana R, Esposito A, Bosari S, Ferrero S,
Gianelli U, Paliotti R, Busca G, Giorgetti A, Magrini F, Rebulla P:
Homing of peripherally injected bone marrow cells in rat
after experimental myocardial injury.  Haematologica 2003,
88:614-621.
5. Crosby JR, Kaminski WE, Schatteman G, Martin PJ, Raines EW, Seifert
RA, Bowen-Pope DF: Endothelial cells of hematopoietic origin
make a significant contribution to adult blood vessel forma-
tion.  Circ Res 2000, 87:728-730.
6. Shintani S, Murohara T, Ikeda H, Ueno T, Honma T, Katoh A, Sasaki
K, Shimada T, Oike Y, Imaizumi T: Mobilization of endothelial
progenitor cells in patients with acute myocardial infarction.
Circulation 2001, 103:2776-2779.
7. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zei-
her AM, Dimmeler S: Number and migratory activity of circu-
lating endothelial progenitor cells inversely correlate with
risk factors for coronary artery disease.  Circ Res 2001,
89:E1-E7.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Respiratory Research 2007, 8:58 http://respiratory-research.com/content/8/1/58
Page 8 of 8
(page number not for citation purposes)
8. Gill M, Dias S, Hattori K, Rivera ML, Hicklin D, Witte L, Girardi L,
Yurt R, Himel H, Rafii S: Vascular trauma induces rapid but
transient mobilization of VEGFR2(+)AC133(+) cells.  Circ Res
2001, 88:167-174.
9. Hristov M, Erl W, Weber PC: Endothelial progenitor cells: isola-
tion and characterization.  Trends Cardiovasc Med 2003,
13:201-206.
10. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Mag-
ner M, Isner JM, Asahara T: Ischemia- and cytokine-induced
mobilization of bone marrow-derived endothelial progeni-
tor cells for neovascularization.  Nat Med 1999, 5:434-438.
11. Wang Y, Ahmad N, Wani MA, Ashraf M: Hepatocyte growth fac-
tor prevents ventricular remodelling and dysfunction in mice
via Akt pathway and angiogenesis.  J Mol Cell Cardiol 2004,
37:1041-1052.
12. Ding S, Merkulova-Rainon T, Han ZC, Tobelem G: HGF receptor
up-regulation contributes to the angiogenic phenotype of
human endothelial cells and promotes angiogenesis in vitro.
Blood 2003, 101:4816-4822.
13. Abounader R, Laterra J: Scatter factor/hepatocyte growth fac-
tor in brain tumor growth and angiogenesis.  Neuro-oncology
2005, 7:436-451.
14. Ceradini D, Gurtner GC: Homing to hypoxia: HIF-1 as a medi-
ator of progenitor cell recruitment to injuried tissues.  Trends
Cardiovasc Med 2005, 15:57-63.
15. Semenza GL: HIF-1 and human disease: one highly involved
factor.  Gene Dev 2000, 14:1983-1991.
16. Semenza GL: Regulation of mammalian O2 homeostasis by
hypoxia-inducible factor 1.  Annu Rev Cell Dev Biol 1999,
15:551-578.
17. Minet E, Michel G, Mottet D, Raes M, Michiels C: Transduction
pathways involved in hypoxia-inducible factor-1 phosphor-
ylation and activation.  Free Radic Biol Med 2001, 31:847-855.
18. Matteucci E, Locati M, Desiderio MA: Hepatocyte growth factor
enhances CXCR4 expression favoring breast cancer cell
invasiveness.  Exp Cell Res 2005, 310:176-185.
19. Maroni P, Bendinelli P, Matteucci E, Desiderio MA: HGF induces
CXCR4 and CXCL12-mediated tumor invasion through
Ets1 and NF-kB.  Carcinogenesis 2006. DOI:10. 93/carcin/bgl129 
20. Laufs U, Werner N, Link A, Endres M, Wassmann S, Jurgens K, Miche
E, Bohm M, Nickenig G: Physical training increases endothelial
progenitor cells, inhibits neointima formation, and enhances
angiogenesis.  Circulation 2004, 109:220-226.
21. Akita T, Murohara T, Ikeda H, Sasaki K, Shimada T, Egami K, Imaizumi
T:  Hypoxic preconditioning augments efficacy of human
endothelial progenitor cells for therapeutic neovasculariza-
tion.  Lab Invest 2003, 83:65-73.
22. Ciulla MM, Giorgetti A, Lazzari L, Cortiana M, Silvestris I, Annoni G,
De Asmundis C, Fiore AV, Montelatici E, Paliotti R, Magrini F, Rebulla
P, Cortelezzi A: High-altitude trekking in the Himalayas
increases the activity of circulating endothelial cells.  Am J
Hematol 2005, 79:76-78.
23. Le QT, Denko NC, Giaccia AJ: Hypoxic gene expression and
metastasis.  Cancer Metastasis Rev 2004, 23:293-310.
24. Ciulla MM, Giorgetti A, Silvestris I, Cortiana M, Montelatici E, Paliotti
R, Annoni GA, Fiore AV, Giordano R, De Marco F, Magrini F, Rebulla
P, Cortelezzi A, Lazzari L: Endothelial Colony Forming Capacity
is Related to C-Reactive Protein Levels in Healthy Subjects.
Curr Neurovasc Res 2006, 3:99-106.
25. Ge RL, Witkowski S, Zhang Y, Alfrey C, Sivieri M, Karlsen T, Resaland
GK, Harber M, Stray-Gundersen J, Levine BD: Determinants of
erythropoietin release in response to short-term hypobaric
hypoxia.  J Appl Physiol 2002, 92:2361-2367.
26. Pohlman TH, Harlan JM: Adaptive Responses of the Endothe-
lium to Stress.  Journal of Surgical Research 2000, 89:85-119.
27. Faller DV: Endothelial cell responses to hypoxic stress.  Clin Exp
Pharmacol Physiol 1999, 26:74-84.
28. Gampel A, Moss L, Jones MC, Brunton V, Norman JC, Mellor H:
VEGF regulates the mobilisation of VEGFR-2/KDR from an
intracellular endothelial storage compartment.  Blood 2006,
108:2624-31.
29. Bunn HF: New agents that stimulate erythropoiesis.  Blood
2006. DOI 10.1182/blood-2006-08-019083
30. Schioppa T, Uranchimeg B, Saccani A, Biswas SK, Doni A, Rapisarda
A, Bernasconi S, Saccani S, Nebuloni M, Vago L, Mantovani A, Melillo
G, Sica A: Regulation of chemokine receptor CXCR4 by
hypoxia.  J Exp Med 2003, 198:1391-1402.
31. Birchmeier C, Birchmeier W, Gherardi E, Ad Vande Woude GF:
Met, metastasis, motility and more.  Neture Rev 2003,
4:915-925.
32. Tacchini L, De Ponti C, Matteucci E, Follis R, Desiderio MA: Hepa-
tocyte growth factor-activated NF-kappaB regulates HIF-1
activity and ODC expression, implicated in survival, differ-
ently in different carcinoma cell lines.  Carcinogenesis 2004,
25(11):2089-2100.
33. Guyenet PG: Neural structures that mediate sympathoexcita-
tion during hypoxia.  Respir Physiol 2000, 121:147-62.
34. Sarkar S, Banerjee PK, Selvamurthy W: High altitude hypoxia: an
intricate interplay of oxygen responsive macroevents and
micromolecules.  Mol Cell Biochem 2003, 253:287-305.
35. Halliwill JR, Morgan BJ, Charkoudian N: Peripheral chemoreflex
and baroreflex interactions in cardiovascular regulation in
humans.  J Physiol 2003, 552:295-302.
36. Papandreou I, Powell A, Lim AL, Denko N: Cellular reaction to
hypoxia: sensing and responding to an adverse environment.
Mutat Res 2005, 569:87-100.
37. Grant S, MacLeod N, Kay JW, Watt M, Patel S, Paterson A, Peacock
A: Sea level and acute responses to hypoxia: do they predict
physiological responses and acute mountain sickness at alti-
tude?  Br J Sports Med 2002, 36:141-146.